What's New :
TARGET PT 2022: Batch will be started from 6th December, 2021
GS PAPER-2 (New Batch will be started from 06th December, 2021)
IAS Foundation 2023-24: New Batch will be started from 14th December, 2021

CCI approves formation of a JV for consumer healthcare products by GSK and Pfizer

  • Category
    Economy
  • Published
    31st May, 2019

Recently, the Competition Commission of India (CCI) has approved the formation of a joint venture for consumer healthcare products by pharmaceutical giants GlaxoSmithKline (GSK) and Pfizer

Context

Recently, the Competition Commission of India (CCI) has approved the formation of a joint venture for consumer healthcare products by pharmaceutical giants GlaxoSmithKline (GSK) and Pfizer.

You must be logged in to get greater insights.
X
Enquire Now